Literature DB >> 34411236

Incidence and mortality rates of intracranial hemorrhage in hemophilia: a systematic review and meta-analysis.

Anne-Fleur Zwagemaker1, Samantha C Gouw1, Julie S Jansen1, Caroline Vuong1, Michiel Coppens2, Qun Hu3, Xiaoqin Feng4, Soon K Kim5, Johanna G Van der Bom6, Karin Fijnvandraat1.   

Abstract

Intracranial hemorrhage (ICH) is a severe complication that is relatively common among patients with hemophilia. This systematic review aimed to obtain more precise estimates of ICH incidence and mortality in hemophilia, which may be important for patients, caregivers, researchers, and health policy makers. PubMed and EMBASE were systematically searched using terms related to "hemophilia" and "intracranial hemorrhage" or "mortality." Studies that allowed calculation of ICH incidence or mortality rates in a hemophilia population ≥50 patients were included. We summarized evidence on ICH incidence and calculated pooled ICH incidence and mortality in 3 age groups: persons of all ages with hemophilia, children and young adults younger than age 25 years with hemophilia, and neonates with hemophilia. Incidence and mortality were pooled with a Poisson-Normal model or a Binomial-Normal model. We included 45 studies that represented 54 470 patients, 809 151 person-years, and 5326 live births of patients with hemophilia. In persons of all ages, the pooled ICH incidence and mortality rates were 2.3 (95% confidence interval [CI], 1.2-4.8) and 0.8 (95% CI 0.5-1.2) per 1000 person-years, respectively. In children and young adults, the pooled ICH incidence and mortality rates were 7.4 (95% CI, 4.9-11.1) and 0.5 (95% CI, 0.3-0.9) per 1000 person-years, respectively. In neonates, the pooled cumulative ICH incidence was 2.1% (95% CI, 1.5-2.8) per 100 live births. ICH was classified as spontaneous in 35% to 58% of cases. Our findings suggest that ICH is an important problem in hemophilia that occurs among all ages, requiring adequate preventive strategies.
© 2021 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2021        PMID: 34411236     DOI: 10.1182/blood.2021011849

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  2 in total

1.  Intracranial Haemorrhage in Haemophilia Patients Is Still an Open Issue: The Final Results of the Italian EMO.REC Registry.

Authors:  Ezio Zanon; Samantha Pasca; Francesco Demartis; Annarita Tagliaferri; Cristina Santoro; Isabella Cantori; Angelo Claudio Molinari; Chiara Biasoli; Antonio Coppola; Matteo Luciani; Gianluca Sottilotta; Irene Ricca; Berardino Pollio; Alessandra Borchiellini; Alberto Tosetto; Flora Peyvandi; Anna Chiara Frigo; Paolo Simioni
Journal:  J Clin Med       Date:  2022-04-01       Impact factor: 4.241

2.  SYMPHONY consortium: Orchestrating personalized treatment for patients with bleeding disorders.

Authors:  Marjon H Cnossen; Iris van Moort; Simone H Reitsma; Moniek P M de Maat; Roger E G Schutgens; Rolf T Urbanus; Hester F Lingsma; Ron A A Mathot; Samantha C Gouw; Karina Meijer; Annelien L Bredenoord; Rieke van der Graaf; Karin Fijnvandraat; Alexander B Meijer; Emile van den Akker; Ruben Bierings; Jeroen C J Eikenboom; Maartje van den Biggelaar; Masja de Haas; Jan Voorberg; Frank W G Leebeek
Journal:  J Thromb Haemost       Date:  2022-06-02       Impact factor: 16.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.